Trump rolls out new tariff policy for generic medicines, 200% levy to kick in after August 2028 transition; move may hit India exports
Former President Donald Trump announced a new tariff policy imposing a 200% levy on generic medicines, set to take effect after a transition period ending in August 2028. This policy could significantly impact India, which is the largest supplier of generic medicines to the U.S. market. Indian exporters may face challenges in maintaining their market share due to the increased costs associated with these tariffs.